Strides Pharma Science informs about press release

20 Jan 2025 Evaluate

Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio’.

The above information is a part of company’s filings submitted to BSE.


Strides Pharma Scien Share Price

593.95 16.55 (2.87%)
08-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1688.75
Dr. Reddys Lab 1108.55
Cipla 1433.45
Lupin 1982.65
Zydus Lifesciences 859.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...